Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis: an Updated Review of Literature

详细信息    查看全文

• 作者：Saurav Chatterjee (1)
  Dharam Jaydeep Kumbhani (2)
  Partha Sardar (3)
  Anasua Chakraborty (4)
  Giuseppe Biondi-Zoccai (5)
  Manpreet Singh Sabharwal (1)
  Richard Ro (1)
  Balaji Pratap (1)
  Chirag P. Bavishi (1)
  Sripal Bangalore (6)
  
• 关键词：Health ; related quality of life ; Surgical aortic valve replacement ; Transcatheter aortic valve replacement ; Transapical ; Transfemoral ; Severe aortic stenosis ; High ; risk patients
• 刊名：Current Cardiology Reports
• 出版年：2014
• 出版时间：April 2014
• 年：2014
• 卷：16
• 期：4
• 全文大小：173 KB
• 参考文献：1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics鈥?013 update: a report from the American Heart Association. Circulation. 2013;127:e6鈥?45. CrossRef
  2. Lindroos M, Kupari M, Heikkil盲 J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;5:1220鈥?. / This study provides an overview of the wide-spread prevalence of aortic stenosis in the elderly, and indicates the need for effective and safe treatment for the same. CrossRef
  3. Ross Jr J, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61鈥?.
  4. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105鈥?0. CrossRef
  5. Sundt TM, Bailey MS, Moon MR, et al. Quality of life after aortic valve replacement at the age of 80 years. Circulation. 2000;102:III70鈥?. CrossRef
  6. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr FDP, Freed MD, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1鈥?42. CrossRef
  7. Bouma BJ, van Den Brink RB, van Der Meulen JH, Verheul HA, Cheriex EC, Hamer HP, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82:143鈥?.
  8. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-B盲rwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231鈥?3. CrossRef
  9. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290鈥? [Epub Jun 13, 2005]. CrossRef
  10. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister Jr BD, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533鈥?. CrossRef
  11. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214鈥?3. CrossRef
  12. Bavry AA, Kumbhani DJ. Indications and techniques of percutaneous procedures: Coronary, Peripheral, and Structural Heart Disease. UK: Springer; 2012. CrossRef
  13. Kodali SK, O'Neill WW, Moses JW, Williams M, Smith CR, Tuzcu M, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107:1058鈥?4. CrossRef
  14. Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46鈥?4. CrossRef
  15. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. Heart Lung Transplant. 2001;20:1016鈥?4. CrossRef
  16. Dolgin M. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Brown and Co; 1994.
  17. Supino PG, Borer JS, Franciosa JA, Preibisz JJ, Hochreiter C, Isom OW, et al. Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. J Card Fail. 2009;15:267鈥?7. CrossRef
  18. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245鈥?5. CrossRef
  19. Failde I, Ramos I. Validity and reliability of the SF-36 Health Survey Questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000;53:359鈥?5. CrossRef
  20. Lukkarinen H, Hentinen M. Assessment of quality of life with the Nottingham Health Profile among patients with coronary heart disease. J Adv Nurs. 1997;26:73鈥?4. CrossRef
  21. The Euro QoL Group. Euro-Qol: a new facility for measurement of health-related quality of life. Health Policy. 1990;16:199鈥?08. CrossRef
  22. Chiappini B, Camurri N, Loforte A, Di Marco L, Di Bartolomeo R, Marinelli G. Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg. 2004;78:85鈥?. CrossRef
  23. Kolh P, Kerzmann A, Honore C, Comte L, Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg. 2007;31:600鈥?. CrossRef
  24. Spaziano M, Carrier M, Pellerin M, Choiniere M. Quality of life following heart valve replacement in the elderly. J Heart Valve Dis. 2010;19:524鈥?2.
  25. Shan L, Saxena A, McMahon R, Wilson A, Newcomb A. A systematic review on the quality of life benefits after aortic valve replacement in the elderly. J Thorac Cardiovasc Surg. 2013;145:1173鈥?9.
  26. Ussia GP, Mule M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J. 2009;30:1790鈥?. CrossRef
  27. Bekeredjian R, Krumsdorf U, Chorianopoulos E, Kallenbach K, Karck M. Katus, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol. 2010;106:1777鈥?1. CrossRef
  28. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597鈥?07. / This study was the first randomized trial that showed mortality benefits with transcatheter aortic valve implantation in comparison with 鈥榮tandard therapy鈥?in patients unable to undergo surgical valve replacement. CrossRef
  29. Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, et al. Placement of Aortic Transcatheter Valves (PARTNER) Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124:1964鈥?2. / This study was a prespecified, prospective cohort nested within the randomized PARTNER trial (cohort B) that showed significant improvements in QoL with TAVR when compared with similar patients on 鈥榮tandard therapy鈥? CrossRef
  30. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187鈥?8. / This study established comparable efficacy and safety of TAVR contrasted with surgical AVR. CrossRef
  31. Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, et al. PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (cohort A). J Am Coll Cardiol. 2012;60:548鈥?8. / This study was a prespecified, prospective cohort nested within the randomized PARTNER trial(cohort A) that showed significant improvements in QoL with TAVR when compared with similar patients undergoing surgical AVR. CrossRef
  32. Grossi EA, Zakow PK, Ribakove G, et al. Comparison of postoperative pain, stress response, and quality of life in port access vs standard sternotomy coronary bypass patients. Eur J Cardiothorac Surg. 1999;16 Suppl 2:S39鈥?2. CrossRef
  33. Walther T, Falk V, Metz S, et al. Pain and quality of life after minimally invasive versus conventional cardiac surgery. Ann Thorac Surg. 1999;67:1643鈥?. CrossRef
  34. Georgiadou P, Kontodima P, Sbarouni E, et al. Long-term quality of life improvement after transcatheter aortic valve implantation. Am Heart J. 2011;162:232鈥?. CrossRef
  35. Gotzmann M, Bojara W, Lindstaedt M, et al. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol. 2011;107:1687鈥?2. CrossRef
  36. Krane M, Deutsch MA, Piazza N, Muhtarova T, Elhmidi Y, Mazzitelli D, et al. One-year results of health-related quality of life among patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1774鈥?1. CrossRef
  37. Alli OO, Booker JD, Lennon RJ, Greason KL, Rihal CS, Holmes Jr DR. Transcatheter aortic valve implantation: assessing the learning curve. J Am Coll Cardiol Intv. 2012;5:72鈥?. CrossRef
  38. Kala P, Tretina M, Poloczek M, Ondrasek J, Malik P, Pokorny P, et al. Quality of life after transcatheter aortic valve implantation and surgical replacement in high-risk elderly patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:75鈥?0. CrossRef
  39. Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, et al. Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation. Euro Interv. 2012;8:437鈥?3.
  40. Amonn K, Stortecky S, Brinks H, Gahl B, Windecker S, Wenaweser P, et al. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Eur J Cardiothorac Surg. 2013;43:34鈥?1. CrossRef
  
• 作者单位：Saurav Chatterjee (1)
  Dharam Jaydeep Kumbhani (2)
  Partha Sardar (3)
  Anasua Chakraborty (4)
  Giuseppe Biondi-Zoccai (5)
  Manpreet Singh Sabharwal (1)
  Richard Ro (1)
  Balaji Pratap (1)
  Chirag P. Bavishi (1)
  Sripal Bangalore (6)
  
  1. Division of Cardiovascular Diseases, St. Luke鈥檚 - Roosevelt Hospital Center, Division of Cardiology, 1111 Amsterdam Avenue, Clark Building, 3rd floor, New York, NY, 10025, USA
  2. Division of Cardiology, University of Texas Southwestern, Dallas, TX, USA
  3. Department of Internal Medicine, Metropolitan Hospital Center-New York Medical College, New York, NY, USA
  4. Division of Pulmonary Medicine and Critical Care, Thomas Jefferson University Hospital, Philadelphia, PA, USA
  5. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
  6. Division of Cardiology, New York University School of Medicine, New York, NY, USA
  
• ISSN：1534-3170

文摘

Recent trials have highlighted the comparable mortality benefits and durability of the results for patients with severe aortic stenosis (AS) and high surgical risk managed with either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (AVR). Various national guidelines and international regulatory bodies have approved TAVR, thereby leading to potential wide usage and dissemination of this technique worldwide. Quality-of-life outcomes, in spite of being an important measure of success and acceptability of the procedure, have not been publicized as extensively. For high risk patients with severe AS, implementation of TAVR has resulted in comparable survival, but different and novel adverse events compared with AVR. We present an updated review focusing on the quality-of-life outcomes and issues with this new and important procedural approach.